Patents
Literature
Hiro is an intelligent assistant for R&D personnel, combined with Patent DNA, to facilitate innovative research.
Hiro

36 results about "Palindrome" patented technology

A palindrome is a word, number, phrase, or other sequence of characters which reads the same backward as forward, such as taco cat or madam or racecar or the number 10801. Sentence-length palindromes may be written when allowances are made for adjustments to capital letters, punctuation, and word dividers, such as "A man, a plan, a canal, Panama!", "Was it a car or a cat I saw?" or "No 'x' in Nixon".

Gene editing of deep intronic mutations

PendingUS20190022192A1Enhance cellular uptakeEnhances cellular uptakeSenses disorderNervous disorderSelf limitingDisease
Provided herein are compositions, methods, kits, and viral particles for treating a disease or disorder associated with a deep intronic mutation using an engineered, non-naturally occurring Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR)-CRISPR associated (Cas) (CRISPR-Cas) system. In some aspects, provided herein is a self-limiting CRISPER-Cas system.
Owner:GENZYME CORP

Mitochondrion tRNA (transfer ribonucleic acid)<Thr> 15909A>G mutation detection method and kit thereof

The invention discloses a mitochondrion tRNA (transfer ribonucleic acid)<Thr> 15909A>G mutation detection method and a kit for detecting mitochondrion tRNA<Thr> 15909A>G mutation. The method includes DNA (deoxyribonucleic acid) extraction, specific primer design, specific band PCR (polymerase chain reaction) amplification, specific restriction endonuclease HpyCH4V enzyme digestion, agarose gel electrophoresis identification and the like. After being subjected to specific PCR amplification, a DNA sample positioned at a tRNA<Thr> 15909A>G mutation position possibly comprises a TGCA palindrome structure which can be specifically recognized by specific restriction endonuclease HpyCH4V, then two small fragments are obtained by rapid enzyme digestion, and two bands are obtained after agarose gel electrophoresis. The mitochondrion tRNA<Thr> 15909A>G mutation detection method and the kit have the advantages that requirements on required detection instruments and required detection reagent cost are low, and according to the required method, simplicity and stability in operation, easiness in rapid mastering, accuracy, good specificity and the like are achieved; the method and the kit are beneficial to establishment of perfect screening technology for tRNA<Thr> mutation and can be widely popularized to clinical detection.
Owner:WENZHOU MAITUO BIOLOGICAL TECH

A kind of emsa method and its probe and the preparation method of the probe

ActiveCN105506150BOvercoming developing errorsNo false negativesMicrobiological testing/measurementBiological testingSingle strandBiotin
The invention discloses an EMSA method, a probe thereof and a preparation method of the probe. The EMSA probe comprises a first strip chain, and the first strip chain comprises a transcription factor combination sequence and joint sequences located at the 5' end and the 3' end of the transcription factor combination sequence. The preparation method of the EMSA probe comprises the following steps of synthesizing a template strand and a primer which is labeled through biotin and modified through LNA, wherein the template strand contains the transcription factor combination sequence and the joint sequences located at the 5' end and the 3' end of the transcription factor combination sequence, each joint sequence is a palindromic sequence, and the nucleotide sequence of the primer is the same as the nucleotide sequence of each joint sequence; adopting the primer for conducting PCR amplification with the template strand as the template and synthesizing the EMSA probe . The EMSA probe can be used for conducting EMSA. According to the EMSA method, the probe thereof and the preparation method of the probe, the double-stranded probe is prepared from a single-strained probe through PCR, false negativeness due to incomplete renaturation is avoided, and developing errors caused by the single-stranded free probe are further overcome.
Owner:GUANGZHOU BIOSENSE BIOSCI
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Try Eureka
PatSnap group products